Castle Biosciences Inc is a molecular diagnostics company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CSTL is expected to report earnings to rise 102.05% to -40 cents per share on August 11
Q2'25
Est.
$-0.40
Q1'25
Missed
by $0.14
Q4'24
Beat
by $0.31
Q3'24
Beat
by $0.08
Q2'24
Beat
by $0.58
The last earnings report on May 05 showed earnings per share of -20 cents, missing the estimate of -5 cents. With 63.43K shares outstanding, the current market capitalization sits at 608.02M.